Skip to main content

Table 1 Laboratory results of the patients

From: Efficacy of nonsurgical tigecycline pleurodesis for the management of hepatic hydrothorax in patients with liver cirrhosis

  Case 1 Case 2
Before pleurodesis After pleurodesis, first 2 weeks (median) Late follow-up Before pleurodesis After pleurodesis, first 2 weeks (median) Late follow-up
CBC
  WBC, 103/mm3 3 1.6a 4.4 5.9 7.1 4.4
  Hb, g/dl 10.3 8.6a 11.3 10 10.6 9.4
  Plt, 103/mm3 49 32 34 150 158 114
INR, range (0.8–1.2) 1.49 2.2a 1.6 1.14 1.19 1.17
AST/ALT, IU/l 59/47 50/30 68/77 36/127 23/17 26/13
GGT/AP, IU/l 17/97 12/71 47/81 26/81 37/127 36/85
T.bil/D.bil, mg/dl 2.1/0.63 2.2/ 0.4 3.74/1.07 1.08/0.3 1.1/0.2 1.4/0.39
Albumin, g/dl 2 2.3 2.4 2.6 2.7 3
Creatinine, mg/dl 0.6 0.57 0.6 0.7 0.7 0.7
Na, mEq/l 134 133 132 141 133 140
MELD score 14 18a 17 9 9 9
CTP class B B B A A A
  1. Abbreviations: CBC complete blood count, INR international normalized ratio, ALT alanine aminotransferase, AST aspartate aminotransferase, GGT gamma-glutamyl transpeptidase, AP alkaline phosphatase, Na sodium, K potassium, CTP Child–Turcotte–Pugh, MELD model for end-stage liver disease, Plt platelet, T.bil total bilirubin, D.bil direct bilirubin
  2. aPathologic changes